Celcuity Inc (CELC)
14.13
-0.50
(-3.42%)
USD |
NASDAQ |
Nov 14, 16:00
14.13
0.00 (0.00%)
After-Hours: 20:00
Celcuity Shareholders Equity (Quarterly): 176.68M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 176.68M |
March 31, 2024 | 133.74M |
December 31, 2023 | 139.77M |
September 30, 2023 | 92.90M |
June 30, 2023 | 110.13M |
March 31, 2023 | 123.23M |
December 31, 2022 | 133.77M |
September 30, 2022 | 43.53M |
June 30, 2022 | 53.19M |
March 31, 2022 | 61.54M |
December 31, 2021 | 68.71M |
September 30, 2021 | 74.47M |
June 30, 2021 | 27.03M |
March 31, 2021 | 35.17M |
December 31, 2020 | 11.70M |
Date | Value |
---|---|
September 30, 2020 | 13.76M |
June 30, 2020 | 15.86M |
March 31, 2020 | 17.52M |
December 31, 2019 | 19.30M |
September 30, 2019 | 20.71M |
June 30, 2019 | 22.39M |
March 31, 2019 | 23.86M |
December 31, 2018 | 25.35M |
September 30, 2018 | 26.91M |
June 30, 2018 | 28.48M |
March 31, 2018 | 29.94M |
December 31, 2017 | 31.39M |
September 30, 2017 | 32.81M |
June 30, 2017 | 4.335M |
December 31, 2016 | 5.612M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
11.70M
Minimum
Dec 2020
176.68M
Maximum
Jun 2024
71.16M
Average
61.54M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
CEL-SCI Corp | 8.473M |
AIM ImmunoTech Inc | 6.102M |
IGC Pharma Inc | 7.88M |
NovaBay Pharmaceuticals Inc | -0.617M |
Protalix BioTherapeutics Inc | 28.58M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 292.54M |
Total Liabilities (Quarterly) | 115.86M |